Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT06401304

Recruiting

Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value) (OncoPROValue-1)

Breast Cancer | Breast Carcinoma in Situ | Breast Cancer Invasive | Breast Asymmetry
NCT03939897

Active, not recruiting

Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Metastatic Breast Carcinoma | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast Carcinoma
NCT00952731

Completed

4-Hydroxytamoxifen or Tamoxifen Citrate in Treating Women With Newly Diagnosed Ductal Breast Carcinoma in Situ

Estrogen Receptor-positive Breast Cancer | Ductal Breast Carcinoma in Situ
NCT06976944

Recruiting

Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer (PRELUDE)

Recurrent Triple-Negative Breast Cancer
NCT05485766

Recruiting

Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer

Breast Cancer | Breast Neoplasms | Triple Negative Breast Cancer | Triple Negative Breast Neoplasms | BRCA1 Mutation | BRCA2 Mutation | BRCA Mutation | BRCA-Associated Breast Carcinoma
NCT04762979

Active, not recruiting

Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer

Hormone Receptor Positive Breast Carcinoma | HER2-negative Breast Cancer | PIK3CA Mutant Metastatic Breast Cancer
NCT00753922

Completed

Core Gel Study of the Safety and Effectiveness of Mentor Round Low Bleed Silicone Gel-filled Mammary Prostheses

Breast Augmentation | Breast Reconstruction | Breast Revision
NCT07367698

Recruiting

Scaffold-guided Breast Implant Revision Surgery

Breast Implant Revision | Breast Augmentation Complications
NCT03617549

Completed

Stress and Breast Milk Study In the Neonatal Intensive Care Unit

Stress | Breast Feeding | Breast Milk Expression
NCT07030569

Recruiting

RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study (RADIOSPHER2)

Breast Cancer | Breast Neoplasms | Breast Carcinoma | HER2-positive Breast Cancer | Breast Cancer Stage IV | Breast Cancer Metastatic | HER2 Positive Breast Carcinoma | Radiomics | Breast Cancer With Bone Metastasis | HER2
NCT06401889

Recruiting

Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage 0 Breast Cancer AJCC v8 | Breast Adenocarcinoma | Estrogen Receptor-Positive Breast Carcinoma | Progesterone Receptor-Positive Breast Carcinoma
NCT07398118

Not yet recruiting

CRYO-1: Cryoablation in Elderly Patients With Early-Stage Breast Cancer. (CRYO-1)

Breast Cancer Stage I | Breast Cancer Early Stage Breast Cancer (Stage 1-3)
NCT07130344

Not yet recruiting

PERCIST Evaluation of Trastuzumab Deruxtecan in the Treatment of HER2 Low Breast Cancer (PERPETUAL)

Metastatic Breast Cancer | HER 2 Low-expressing Breast Cancer
NCT07015853

Not yet recruiting

ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation

Breast Cancer | TNBC - Triple-Negative Breast Cancer
NCT06995118

Recruiting

The Application of "HUAXI Hole 1" in Reverse-sequence Endoscopic Nipple-sparing Mastectomy With Direct-to-implant Breast Reconstruction (HUAXI-h-01)

Breast Cancer Early Stage Breast Cancer (Stage 1-3)
NCT06949046

Recruiting

Effects of a Nursing-led Communication Using Mobile Health Information in Breast Cancer Patients Undergoing Concurrent Chemotherapy (breast cancer)

Breast Cancer Early Stage Breast Cancer (Stage 1-3)
NCT06943911

Not yet recruiting

Reflects the Intervention (AI Chatbot) (BC-CHAT)

Breast Cancer Early Stage Breast Cancer (Stage 1-3)
NCT06505018

Recruiting

Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line Treatment (ALTERNATIVE)

Metastatic Triple-Negative Breast Carcinoma
NCT06405828

Recruiting

Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer (ACCESS)

Metastatic Breast Cancer | Stage IV Breast Cancer AJCC V7
NCT05952557

Recruiting

An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) (CAMBRIA-2)

Breast Cancer, Early Breast Cancer
NCT05834582

Recruiting

Neoadjuvant Fluzoparib in Germline BRCA-mutated Three-negative Breast Cancer Breast Cancer

TNBC - Triple-Negative Breast Cancer
NCT05491226

Recruiting

Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation

Breast Cancer | TNBC - Triple-Negative Breast Cancer
NCT05475678

Recruiting

Clinical Study of Camrelizumab Combined With TCb Versus TCb in Neoadjuvant Treatment of Triple-negative Breast Cancer

Breast Cancer | Triple Negative Breast Cancer | Camrelizumab
NCT05076695

Recruiting

Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast Cancer (NeoTPPF)

HER2-positive Breast Cancer | Estrogen Receptor-positive Breast Cancer
NCT04429269

Recruiting

A Comparative Study of Mammography and Ultrasound for Breast Cancer Screening and Early Diagnosis (MUSD)

Breast Cancer Screening | Breast Cancer Diagnosis
NCT03598257

Active, not recruiting

Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer

Breast Inflammatory Carcinoma
NCT07521397

Completed

Pooled Analysis of Patients With Early-stage Breast Cancer Treated With Adjuvant Dose-dense Sequential Chemotherapy: a Hellenic Cooperative Oncology Group (HeCOG) Study. (ΗE_10R/22)

Breast Cancer | Early Stage Breast Cancer | Adjuvant Chemotherapy | Overall Survival | Prognosis Breast Cancer
NCT03709082

Terminated

Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

HER2-positive Breast Cancer | Breast Cancer Metastatic
NCT02012634

Unknown

Metronomic Chemotherapy of Capecitabine After Standard Adjuvant Chemotherapy in Operable Triple Negative Breast Cancer (MACRO)

Breast Cancer | Triple Negative Breast Cancer | Capecitabine
NCT05012176

Completed

An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8
NCT06831955

Recruiting

LifEStyle Intervention to Enhance Efficacy of Neoadjuvant Therapy in Patients With Triple Negative Breast Cancer (LESLIE)

Triple Negative Breast Cancer (TNBC), Early Setting
NCT04159818

Recruiting

Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients (TONIC-2)

Metastatic Breast Cancer
NCT02326974

Active, not recruiting

T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA

Breast Cancer | Stage II Breast Cancer | HER-2 Positive Breast Cancer | Stage III Breast Cancer
NCT04108858

Terminated

Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Maintenance Treatment (Trastuzumab and Pertuzumab) After Initial Chemotherapy in a Phase Ib/II Trial for Advanced HER2 Positive Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Breast Carcinoma | HER2-Positive Breast Carcinoma
NCT04734262

Active, not recruiting

A Phase II Study to Explore the Safety, Tolerability, and Preliminary Antitumor Activity of Sitravatinib Plus Tislelizumab or Combination With Nab-paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) (SPARK)

Metastatic Breast Cancer
NCT02066532

Completed

Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer

Metastatic Breast Cancer | Breast Carcinoma | HER-2 Positive Breast Cancer
NCT03055312

Terminated

Bicalutamide in Treatment of Androgen Receptor (AR) Positive Metastatic Triple Negative Breast Cancer (SYSUCC-007)

Metastatic Triple Negative Breast Cancer
NCT04790305

Recruiting

Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer

Triple-negative Breast Cancer | Carcinoma Breast | Invasive Ductal Carcinoma, Breast
NCT02311933

Active, not recruiting

Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer

Recurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7
NCT04090567

Recruiting

Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC v8 | Prognostic Stage III Breast Cancer AJCC v8 | Prognostic Stage IIIA Breast Cancer AJCC v8 | Prognostic Stage IIIB Breast Cancer AJCC v8 | Prognostic Stage IIIC Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8
NCT07268105

Withdrawn

Flange Fitting for NICU Pumping Parents to Explore Improved Milk Production and Satisfaction

Breast Pumping | Human Milk/Breastfeeding
NCT07443774

Not yet recruiting

Evaluation of Adherence to Cell Cycle Inhibitors Used as Adjuvant Therapy in Patients With Localized Breast Cancer at High Risk of Recurrence. (AdheRA)

Breast Cancer | Early Breast Cancer | Endocrine Therapy | ER+ Breast Cancer | Ribociclib | Abemaciclib
NCT07107217

Not yet recruiting

Camrelizumab in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-negative Breast Cancer (Camella)

Breast Cancer
NCT06955156

Recruiting

Trilaciclib Combined With Anti-PD-1 Antibody and Chemotherapy in the Treatment of Locally Advanced TNBC

Triple Negative Breast Cancer
NCT06954480

Recruiting

Investigating Datopotamab Deruxtecan Plus Durvalumab Versus Datopotamab Deruxtecan in Patients With PDL1-negative Metastatic Triple-negative Breast Cancer (DIAMOND)

Triple Negative Breast Cancer
NCT06926920

Recruiting

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

Triple Negative Breast Cancer
NCT06810492

Not yet recruiting

The Efficacy and Safety of CDK4/6 Inhibitors in Combination with Endocrine Therapy in the Neoadjuvant Treatment

Breast Cancer Stage II | Breast Cancer Stage III
NCT06802757

Recruiting

Posaconazole Plus PD-1 Inhibitors and Chemotherapy vs PD-1 Inhibitors and Chemotherapy in Neoadjuvant Therapy for Triple Negative Breast Cancer (PRISM-TNBC)

Breast Cancer
NCT06709651

Recruiting

Microbiome Immunotherapy Neoadjuvant Assessment (MINA)

Triple Negative Breast Cancer
NCT06516289

Recruiting

Neoadjuvant Treatment of gBRCA-Mutated HER2-Negative Breast Cancer With HRS-1167 and Famitinib ± Camrelizumab

HER2-negative Breast Cancer | BRCA-Mutated Breast Carcinoma

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations